Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Does, C.
Right arrow Articles by Driessen, A. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Does, C.
Right arrow Articles by Driessen, A. J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 4, 2472-2478, January 28, 2000


Non-bilayer Lipids Stimulate the Activity of the Reconstituted Bacterial Protein Translocase*

Chris van der Does, Jelto Swaving, Wim van Klompenburg, and Arnold J. M. DriessenDagger

From the Department of Microbiology and the Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Kerklaan 30, 9751 NN Haren, The Netherlands

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

To determine the phospholipid requirement of the preprotein translocase in vitro, the Escherichia coli SecYEG complex was purified in a delipidated form using the detergent dodecyl maltoside. SecYEG was reconstituted into liposomes composed of defined synthetic phospholipids, and proteoliposomes were analyzed for their preprotein translocation and SecA translocation ATPase activity. The activity strictly required the presence of anionic phospholipids, whereas the non-bilayer lipid phosphatidylethanolamine was found stimulatory. The latter effect could also be induced by dioleoylglycerol, a lipid that adopts a non-bilayer conformation. Phosphatidylethanolamine derivatives that prefer the bilayer state were unable to stimulate translocation. In the absence of SecG, activity was reduced, but the phospholipid requirement was unaltered. Remarkably, non-bilayer lipids were found essential for the activity of the Bacillus subtilis SecYEG complex. Optimal activity required a mixture of anionic and non-bilayer lipids at concentrations that correspond to concentrations found in the natural membrane.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Complementary genetic and biochemical approaches have shown that the translocation of proteins across the inner membrane of Escherichia coli is mediated by the translocase (for reviews see Refs. 1-3). The essential subunits of the translocase are the dissociable peripheral ATPase termed SecA and integral membrane proteins SecY and SecE (4, 5). The SecYE complex forms a preprotein-conducting channel that may associate with SecG or the heterotrimeric SecDFYajC complex (6). SecA binds with high affinity to the SecYEG complex and functions as a molecular motor that utilizes the binding and hydrolysis of ATP to drive the stepwise translocation of a preprotein across the membrane (7). In addition, the proton motive force accelerates the translocation reaction (8).

Phospholipids have been shown to play an important role in protein translocation. The E. coli inner membrane mostly consists of the zwitterionic phospholipid phosphatidylethanolamine (PE,1 70-75%) and two anionic phospholipids, phosphatidylglycerol (PG, 20-25%) and cardiolipin (CL, 5-10%). The membrane lipid composition is normally tightly regulated, but by the use of strains engineered in the expression of critical phospholipid biosynthetic enzymes, the in vivo manipulation of the bulk phospholipid composition has been achieved (9). The major anionic phospholipids PG and CL can be depleted in a strain in which the expression of the pgsA gene encoding the phosphatidylglycerophosphate synthase is controlled. At low PG and CL content (2-3%), protein translocation is severely compromised, whereas lack of only CL did not affect translocation (10). Only the negative charge of the polar lipid head group is important as many other anionic phospholipids are able to restore the protein translocation activity of PG and CL-depleted inner membrane vesicles (IMVs) or in reconstituted proteoliposomes (4, 11, 12). The efficiency of protein translocation is directly proportional to the amount of anionic phospholipids (13). Anionic phospholipids influence various steps in the preprotein translocation cascade as follows. (i) They promote the interaction of SecA with the membrane surface (14-16) and SecYEG (11) and are needed for the SecA translocation ATPase activity, i.e. the preprotein-stimulated ATPase activity of the SecYEG-bound SecA (12, 14). At low levels of anionic phospholipids, excess SecA can compensate for the reduced translocation activity (17), suggesting a role of these lipids in the targeting of preproteins and SecA to the membrane. In addition, the endogenous SecA ATPase activity at low Mg2+ concentration is stimulated by the presence of anionic phospholipids, an activity termed SecA lipid ATPase (14). (ii) Membrane insertion of the positively charged signal sequence of a preprotein is dependent on anionic phospholipids (18-22). (iii) Anionic phospholipids stabilize the SecYEG complex during octyl glucoside solubilization (12, 23) and (iv) influence the acquisition of the correct topology of membrane proteins (24).

The cold-sensitive growth defect of a secG null strain (25-28) can be suppressed by various gene products involved in phospholipid biosynthesis along with the pgsA gene. Likewise, the cold-sensitive growth defect of the secAcsR11 mutant strain is suppressed by overproduction of the PgsA protein (28). These effects have been attributed to an increase in the anionic phospholipid content that restores the secretion defect of these strains by facilitating the SecA catalytic cycle at low temperature (28). The exact mechanism of this activation, however, remains obscure as studies with photoreactive phospholipid analogues suggest that the SecYEG-bound, membrane-inserted form of SecA is not in contact with phospholipids (29, 30).

The other main phospholipid of the E. coli inner membrane is the type II lipid PE. PE adopts a non-bilayer hexagonal II phase conformation (31). Deletion of the pssA gene (32), which encodes the phosphatidylserine (PS) synthase, renders cells devoid of the amino-based phospholipids PS and PE. This results in severe pleiotropic effects on membrane protein function and the inactivation of protein translocation (33-35). For growth, this strain is dependent on the presence of a high concentration of divalent cations (Ca2+, Mg2+, or Sr2+) (32, 35). These cations stimulate the bilayer to non-bilayer transition of CL, which comprises 44% of the total phospholipid in this strain (36). It therefore appears that the polymorphic behavior of these lipids is essential for growth, a role normally fulfilled by PE. The requirement for non-bilayer lipids for protein translocation appears less strict than for anionic lipids (35), but the mechanism by which these lipids act on protein translocation is unknown. Non-bilayer lipids only marginally affect the SecA lipid ATPase activity (37) and appear not essential for the functional reconstitution of protein translocation using octyl glucoside (OG)-purified SecYEG complex (11).

The reconstitution of preprotein translocation with only a limited set of purified Sec proteins provides a unique opportunity to assess systematically the lipid requirement for preprotein translocation. We now report on a method that allows purification of the SecYEG complex in a delipidated state. The activity of the delipidated SecYEG can be restored after reconstitution into liposomes with a defined phospholipid composition. The data with the purified E. coli SecYEG complex not only confirm the hypothesis that anionic lipids are essential for activity but also show that non-bilayer lipids stimulate the activity of the reconstituted translocase. Strikingly, with the Bacillus subtilis SecYEG both lipid classes are essential for activity. Overall, optimal activity is observed when anionic and non-bilayer lipids are present at a concentration that matches that of the natural membrane.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Plasmids-- pET610 (38) was partially digested with NcoI/BamHI, and the large secYE fragment was cloned into pET302 (39) to yield pET320 that allows the overproduction of the E. coli SecYE.

Materials-- E. coli SecA (40), B. subtilis SecA (41), SecB (42), pro-OmpA (43), and pre-PhoB (44) were purified as described. ProOmpA and pre-PhoB were labeled by iodination with K125I (44) and stored frozen in 6 M urea, 50 mM Tris-Cl, pH 7.5, 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), N-methyl-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (methyl-DOPE), N,N-dimethyl-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (dimethyl-DOPE), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dimyristoyl-oleoyl-sn-glycero-3-phosphoethanolamine (DMPE), 1,2-dioleoyl-sn-glycero-3-[phospho-L-serine] (DOPS), 1,2 dioleoyl-sn-glycero-3-phosphoglycerol (DOPG), and dioleoylglycerol (DOG) were from Avanti Polar lipids, Inc., Birmingham, AL. Polyclonal antibodies raised against purified His-tagged SecY and SecE and against a synthetic peptide corresponding to a SecG domain were obtained as described previously (39).

Purification of Delipidated SecYEG and SecYE Complexes-- IMVs overexpressing His-tagged SecYE(G) were isolated from E. coli SF100 cells transformed with pET610 (E. coli SecYEG) (39) or pET320 (E. coli SecYE) (this study) as described (39). IMVs (60 mg of protein) were solubilized on ice for 30 min at 1 mg/ml in 10 mM Tris-Cl, pH 8.0, and 20% glycerol (buffer A) supplemented with 2% (w/v) dodecyl maltoside (DDM). Non-solubilized proteins and aggregates were removed by centrifugation (30 min at 40,000 × g at 4 °C), and the supernatant was loaded onto a DEAE column (volume 60 ml) (Whatman, DE52) equilibrated with buffer A supplemented with 0.03% (w/v) DDM. The column was washed with 2 volumes of equilibration buffer, and proteins were eluted with a linear gradient of 0-300 mM KCl in 3 volumes of the same buffer. Alternatively, the SecYEG complex was extracted from the IMVs and purified with 1.25% (w/v) OG in the presence or absence of 0.2 mg/ml of E. coli phospholipid. Fractions were analyzed by 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie Brilliant Blue. Purified protein was either stored on ice or frozen in liquid nitrogen and then stored at -80 °C.

Reconstitution of SecYEG and SecYE Complexes-- Synthetic phospholipids were mixed in desired ratios in chloroform solution, dried under vacuum, washed with ethanol, and dried again. Next, the lipid film was slowly (1-2 h) hydrated at a final concentration of 10 mg/ml by incubation at room temperature under a nitrogen atmosphere in a buffer containing 10 mM Tris-Cl, pH 8.0, and 1 mM dithiothreitol. The suspension was finally dispersed by the use of a bath sonicator. For reconstitution, 100 µl of purified E. coli SecYEG or SecYE protein (about 0.1 mg/ml) was mixed with 20 µl of lipids (10 mg/ml), incubated for 5 min on ice, and diluted rapidly with 8 ml of 50 mM Tris-Cl, pH 8.0, 50 mM KCl. After 5 min, proteoliposomes were collected by centrifugation (30 min, Ti-70, 200,000 × g at 4 °C) and resuspended in 100 µl of 50 mM Tris-Cl, pH 8.0, and 50 mM KCl. Proteoliposomes were analyzed for the amount of incorporated protein using the DC Protein assay (Bio-Rad), by 15% SDS-PAGE stained with Coomassie Brilliant Blue, and by immunoblotting on polyvinylidene difluoride membranes using antibodies directed again SecY, SecE, and SecG. Reconstituted SecYE(G) proteoliposomes were frozen and stored in liquid nitrogen. Before use, samples were thawed at 37 °C and sonicated 3 times for 10 s in a bath sonicator. Control experiments showed that the SecA translocation ATPase activity after rapid dilution was linear with the amount of SecYEG added at lipid-to-protein ratios (w/w) above 10.

To reconstitute the B. subtilis SecYEG into liposomes of different lipid compositions, IMVs were isolated from E. coli SF100 cells transformed with pET822 that directs the functional overexpression of the B. subtilis SecYEG complex (45). IMVs (100 µl; 0.1 mg of protein/ml) were solubilized in 1.25% (w/v) OG in buffer A as described (39). After 30 min incubation on ice, the non-solubilized material was removed by centrifugation (TLA100.4, 30 min, 180,000 × g at 4 °C). The supernatant fraction (100 µl) was subsequently mixed with 20 µl of lipids (10 mg/ml), rapidly diluted, and isolated as described above. In control experiments, IMVs were used derived from E. coli SF100 cells transformed with pET610 that overproduce E. coli SecYEG (38).

Fusion of SecYEG Proteoliposomes-- SecYEG (proteo)liposomes (100 µl; containing 0, 10, or 20 µg of SecYEG protein and 0.2 mg of phospholipids) were mixed with an equal volume and amount of (proteo)liposomes of different lipid composition. Samples were quickly frozen in liquid nitrogen and slowly thawed on ice. This procedure was repeated three times. Before use in activity assays, samples were sonicated 3 times for 10 s in a bath sonicator.

Translocation Assays-- Translocation assays were performed in a final volume of 50 µl consisting of 50 mM HEPES-KOH, pH 7.6, 30 mM KCl, 5 mM Mg(Ac)2, 2 mM ATP, 10 mM creatine phosphate, 0.5 µg of creatine kinase, 25 µg of bovine serum albumin, 1.6 µg of SecB, 1 µg of purified E. coli or B. subtilis SecA, and proteoliposomes containing 6.5 µg of SecYEG or SecYE complex. Samples were preincubated for 10 min at 37 °C, and the translocation reaction was started by the addition of 1 µl of 125I-labeled pro-OmpA or pre-PhoB (0.2 mg/ml in 6 M urea, 50 mM Tris-Cl, pH 7.5). After 10 min, reactions were terminated by chilling on ice. Samples were treated with proteinase K (0.1 mg/ml) for 15 min, precipitated with ice-cold 10% (w/v) trichloroacetic acid, acetone-washed, and analyzed by SDS-PAGE on 10 (pre-PhoB) and 12% (pro-OmpA) polyacrylamide gels.

Other Analytical Techniques-- Translocation ATPase activity of urea-treated IMVs or SecYEG proteoliposomes was measured with pro-OmpA as substrate as described (46). Protein concentration was determined with the DC Protein assay (Bio-Rad). Phospholipid phosphorus was assayed after heat destruction of chloroform/methanol-extracted phospholipids using the method of Rouser et al. (47).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Purification and Delipidation of SecYEG Complex-- For the purification of the OG-solubilized SecYEG complex, the presence of at least 0.2 mg/ml E. coli phospholipids is essential to retain activity (5, 12, 23). To assess the phospholipid dependence of the translocase in a systematic manner, it is necessary to deplete the purified SecYEG complex of endogenous lipids. When OG was replaced with DDM, the addition of phospholipids was no longer required to purify the SecYEG complex in a functional state. DDM-solubilized and -purified SecYEG complex was as active as complex purified from OG-solubilized membranes in the presence of added phospholipids (Table I). The final amount of endogenous phospholipid present in the DDM-solubilized SecYEG complex was below the detection limit, which corresponds to less than 3 mol of phospholipid per mol of SecYEG complex, assuming an equimolar stoichiometry of the subunits. In contrast, the OG-purified enzyme retained about 200 mol of phospholipid per mol of SecYEG. These data demonstrate that the SecYEG complex can be purified in a delipidated and functional state with the detergent DDM.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Purification of the E. coli SecYEG complex

Reconstitution of SecYEG and Lipid Dependence-- Delipidated SecYEG complex was used to examine the phospholipid requirement of protein translocation. The phospholipid composition of the E. coli inner membrane corresponds to about 70 mol % of the non-bilayer lipid PE and 30 mol % of the acidic PG and CL. To mimic the native polar head group composition, the SecYEG complex was reconstituted into liposomes composed of 70 mol % of DOPE and 30 mol % of DOPG. The amount of DOPC was gradually replaced by DOPG to analyze the requirement for anionic phospholipids. Total amounts of SecY, SecE, and SecG reconstituted in the liposomes were determined by Western blotting and were equal for each of the proteoliposomes (data not shown). Proteoliposomes were supplemented with SecA and analyzed for the SecA ATPase activity in the absence and presence of the precursor pro-OmpA (Fig. 1B) and for the translocation of chemical amounts of 125I-labeled pro-OmpA (Fig. 1A). The activity was determined after 10 min of incubation, and within this time interval, the amount of translocated pro-OmpA increased linearly in time (data not shown). SecYEG was completely inactive when reconstituted into DOPC:DOPE (30:70, molar ratio) (Fig. 1, A and B) but became activated when the DOPC was replaced for DOPG or DOPS (Fig. 1A). A similar observation was made for the endogenous and pro-OmpA-stimulated SecA ATPase activity (Fig. 1B). The requirement for the other main lipid constituent of the E. coli inner membrane, PE, was determined by reconstitution of the SecYEG complex into liposomes composed of DOPG:DOPC (30:70, molar ratio) whereby the DOPC was gradually replaced for DOPE. Unlike DOPG, DOPE appears not to be essential for protein translocation activity. A low but significant translocation (Fig. 1C) and translocation ATPase (Fig. 1D) activity was observed with the SecYEG complex reconstituted in the absence of DOPE. However, DOPE markedly stimulated the activity of SecYEG to 3-fold. These results show that anionic phospholipids are essential for the reconstitution of a functional translocase using purified and delipidated SecYEG, whereas PE is stimulatory.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 1.   Anionic lipid and phosphatidylethanolamine requirement for the functional reconstitution of the E. coli SecYEG complex. Dodecyl maltoside-purified SecYEG was reconstituted in liposomes composed of the indicated synthetic phospholipids and analyzed for the ATP-dependent translocation of 125I-pro-OmpA (A/C) and the SecA ATPase activity in the presence (filled bars) and absence of pro-OmpA (open bars) (B/D).

Phospholipids Reversibly Influence Translocase Activity-- To exclude the possibility that the observed phospholipid requirement is due to a difference in reconstitution efficiency, the SecYEG complex was first reconstituted into proteoliposomes composed of a lipid mixture that does not support activity. Subsequently, other lipids were introduced into these inactive proteoliposomes by freeze-thawed induced fusion with liposomes of different phospholipid composition. SecYEG proteoliposomes composed of DOPC were essentially inactive (2% activity) for the pro-OmpA-stimulated SecA ATPase activity (Fig. 2). Activity could, however, be restored by fusion of these proteoliposomes with DOPG:DOPC:DOPE (30:20:50, molar ratio) liposomes yielding a final lipid composition of DOPG:DOPC:DOPE (15:60:25, molar ratio). The activity of these fused proteoliposomes was about 65% of a control in which the SecYEG complex was reconstituted directly into this lipid mixture (Fig. 2). In another experiment, SecYEG was reconstituted with DOPG:DOPC (30:70, molar ratio) yielding proteoliposomes that support a low SecA translocation ATPase activity. Re-introduction of DOPE into these proteoliposomes by fusion with DOPC:DOPE (50:50, molar ratio) liposomes, again yielding a final lipid composition of DOPG:DOPC:DOPE (15:60:25, molar ratio), resulted in an increase of the activity to about 60% of the control. These results demonstrate that the activity of the reconstituted SecYEG complex can be reversibly modulated by the bulk phospholipid composition.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 2.   Reversible activation of reconstituted SecYEG by DOPE. SecYEG was reconstituted in proteoliposomes of the indicated lipid compositions, and as indicated by the arrows, equal volumes of proteoliposomes were fused by repeated freeze-thawing steps. The amount of reconstituted SecYEG was 0, 10, and 20 µg, indicated by -, +, and ++, respectively. The pro-OmpA-stimulated SecA ATPase activity of the original and fused proteoliposomes was measured as described under "Experimental Procedures." The activity of the SecYEG reconstituted into liposomes composed of DOPG:DOPC:DOPE (15:60:25, molar ratio) which had undergone similar freeze thawing cycles was set to 100%.

Non-bilayer Lipids Stimulate Protein Translocation-- To examine further the effect of the non-bilayer lipid PE on protein translocation, the head group and acyl chain properties were varied. In a lipid mixture of DOPC:DOPG (70:30, molar ratio), the DOPC was gradually replaced for either DOPE, methyl-DOPE, or dimethyl-DOPE. Although introduction of DOPE significantly stimulated the pro-OmpA translocation activity (Fig. 3A) and SecA translocation ATPase (Fig. 3B) of SecYEG proteoliposomes, this effect was largely abolished when the DOPE was mono- or dimethylated. When the DOPE was exchanged for dimyristoyl-PE (DMPE), a PE derivative with a shorter hydrophobic acyl chain, hardly any stimulation of the activity was observed (Fig. 3). Since the methylated forms of PE and DMPE are all bilayer lipids (31, 48), it appears that the stimulatory effect of DOPE is indeed due to its ability to form non-bilayer structures. To confirm this hypothesis further, the effect of dioleoylglycerol (DOG), a lipid with strong non-bilayer forming properties, was examined. DOG markedly stimulated the activity of the SecYEG complex to the same extent as DOPE (Fig. 3). Taken together these data demonstrate that PE affects protein translocation by its ability to adopt a non-bilayer conformation.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 3.   Non-bilayer lipids stimulate preprotein translocation. Purified SecYEG complex was reconstituted in DOPG:DOPC (30:70, molar ratio) proteoliposomes in which the DOPC was gradually replaced for DOPE (open circles), methyl-DOPE (open squares), dimethyl DOPE (closed squares), DMPE (open triangles), or DOG (closed circles). Proteoliposomes were supplemented with SecA and assayed for the ATP-dependent translocation of 125I-pro-OmpA (A) and for the SecA-ATPase activity in the absence and presence of pro-OmpA (B).

The Lipid Requirement of the SecYE Complex Is Not Affected by SecG-- To determine if the presence of SecG influences the lipid requirement of translocation, the SecYE complex was purified from an overexpressing strain and reconstituted into various lipid mixtures. Although some endogenous SecG co-purified with SecYE, Western blotting demonstrated that the amount of SecG in the SecYE proteoliposomes was at least 25-fold lower than in the SecYEG proteoliposomes (data not shown). The absence of SecG resulted in a dramatic reduction of the activity of the SecYE complex. However, the requirement for anionic phospholipids (DOPG) and non-bilayer lipids (DOPE) (Fig. 4) as observed with the SecYE complex was indistinguishable from that found for SecYEG. This indicates that there is no direct mechanistic relation between the SecG function and the activating effect of lipids.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 4.   Lipid dependence of SecYEG and SecYE-mediated pro-OmpA translocation. Purified SecYE and SecYEG was reconstituted into liposomes with the indicated lipid compositions and analyzed for the translocation of 125I-labeled pro-OmpA.

Lipid Requirement of the B. subtilis SecYEG Complex-- To determine if the lipid requirement found for the E. coli SecYEG complex extends to other bacterial species, the lipid specificity of the B. subtilis SecYEG complex was determined. Unlike E. coli, anionic phospholipids are the major constituents of the B. subtilis cytoplasmic membrane, i.e. 70% PG, 4% CL, and 12% PE (49). To obtain functional B. subtilis translocase, the SecY, SecE, and SecG proteins were overproduced in E. coli (45). IMVs derived from cells overexpressing either the B. subtilis or E. coli SecYEG were solubilized in OG without the addition of exogenous lipids and directly reconstituted into a 20-fold excess of synthetic lipids by rapid dilution. A mixture of DOPG:DOPE (70:30, molar ratio) was used to mimic the lipid composition of B. subtilis. Either the DOPG or DOPE was replaced for DOPC to analyze the requirement for anionic and non-bilayer lipids, respectively. The translocation activity of the B. subtilis SecYEG complex was assayed in the presence of purified B. subtilis SecA and 125I-labeled pre-PhoB, a Bacillus-specific precursor (44, 45). 125I-Pro-OmpA was used with the E. coli SecYEG proteoliposomes. Translocation of pro-OmpA by the E. coli SecYEG proteoliposomes again showed the strict requirement for PG and stimulation by PE (Fig. 5). The presence of 25 mol % of PG and 30 mol % of PE in the E. coli SecYEG proteoliposomes was already sufficient to saturate the activity (see also Fig. 1, C and D). Therefore, it seems that the E. coli SecYEG is most active in a synthetic lipid mixture that resembles the polar head group composition of the E. coli inner membrane. Remarkably, translocation of pre-PhoB by B. subtilis SecYEG proteoliposomes appeared much more critical with respect to the lipid composition. Maximal translocation activity required a very high DOPG concentration (Fig. 5) and was optimal in a lipid mixture corresponding closely to the polar head group composition of the B. subtilis membrane, i.e. DOPG:DOPE (70:30, molar ratio) (Fig. 5). The data suggest that the requirement for anionic and non-bilayer lipids for preprotein translocation is a general feature of bacterial translocase complexes and further show that in B. subtilis non-bilayer lipids are essential for activity.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 5.   Comparison of the lipid dependence of B. subtilis and E. coli SecYEG-mediated preprotein translocation. IMVs containing highly overproduced B. subtilis or E. coli SecYEG complex were solubilized in octyl glucoside and reconstituted in proteoliposomes with the indicated lipid compositions. Proteoliposomes were supplemented with purified B. subtilis or E. coli SecA protein, and analyzed for the ATP-dependent translocation of 125I-labeled pre-PhoB or pro-OmpA as indicated.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The E. coli preprotein translocase depends for its activity on specific classes of phospholipids. Previous in vivo and in vitro studies have shown that anionic phospholipids are essential for activity, whereas non-bilayer lipids are stimulatory (for review see Ref. 51). A systematic study of the phospholipid requirement of the purified translocase has not been reported despite the fact that the lipid composition of the reconstituted proteoliposomes can be manipulated in a convenient and systematic manner. We now show that functional reconstitution of the purified, delipidated E. coli SecYEG requires anionic phospholipids, whereas non-bilayer lipids stimulate translocation. These results confirm the studies performed in the crude membrane system but, in addition, extend these observations to the B. subtilis SecYEG. Remarkably, the activity of the B. subtilis SecYEG strictly depends on the presence of non-bilayer lipids. For optimal activity, anionic and non-bilayer lipids need to present at amounts corresponding to the phospholipid composition of the native inner membrane.

In order to analyze the phospholipid requirement of the purified translocase, it is desirable to first delipidate the enzyme and subsequently restore its activity by reconstitution in liposomes with a defined phospholipid composition. The SecYEG complex has been purified from IMVs after solubilization with OG. However, to obtain a functional SecYEG complex it is necessary to include phospholipids in the buffers used during the purification (Refs. 5, 12, and 23 and this study). Delipidation of OG-purified SecYEG leads to the irreversible inactivation of the enzyme (Table I). We now show that SecYEG can be purified in a delipidated and functional form when DDM is used as a detergent instead of OG. OG is a detergent with a rather short acyl chain of only eight carbon moieties. The acyl chain of DDM is longer and thus may more closely resemble the interaction of the phospholipid acyl chain with the SecYEG complex present in detergent micelles. In this respect, it was previously noted that OG-solubilized SecYEG is thermolabile (39, 51, 52). DDM-purified SecYEG complex is less susceptible to such thermal inactivation.2 The DDM-purified SecYEG complex, like the OG-purified, lipid-supplemented SecYEG complex (39), supports the high affinity binding of SecA, the nucleotide-induced conformational states of SecA, and the endogenous SecA ATPase activity.3 However, it has not been possible to detect SecA translocation ATPase activity with the detergent-solubilized translocase even though the enzyme is stable at the temperatures that support this activity in reconstituted liposomes. Electron microscopic studies on the B. subtilis SecYE complex indicate the presence of oligomeric forms that may constitute the preprotein conducting channel (53). This oligomeric form may be a stable state of the SecYE complex, but alternatively, the SecYE oligomer may be a dynamic entity, disassembling and assembling in response to the demand for translocation. When reconstituted into a lipid membrane, the kinetics of such an assembly event will largely be dictated by the lateral protein diffusion rate. In detergent micelles, however, assembly will be limited by the rate of collision within the three-dimensional space and/or the ability of the micelles to fuse. These events may be effective only when the enzyme is present at a very high concentration. Strikingly, preprotein translocation in detergent solution has been reported for the Sec61p isolated from the endoplasmic membrane of yeast (54) but is observed only at a very high Sec61p concentration.

Although the purification method in the absence of phospholipids was developed to be able to examine the effects of small quantities of phospholipids on the activity of the translocase, the data show that high concentrations of anionic and non-bilayer lipids are needed to saturate the translocation activity. It thus appears that phospholipids act on protein translocation in a more global sense. The E. coli SecYEG complex is maximally active in a mixture of 30% DOPG and 70% DOPE. As far as the ratio between anionic and non-bilayer lipids concerns, this mixture "more or less" corresponds to the lipid composition of the E. coli inner membrane. The activity in the optimal synthetic mixture is about 75% of that found with natural E. coli phospholipids, showing that substantial activity can be recovered with the defined system. Reconstituted B. subtilis SecYEG complex is maximally active in 70% DOPG and 30% DOPE, i.e. at a ratio that closely matches that of anionic to non-bilayer lipids in the native B. subtilis inner membrane. It is remarkable that both systems differ in their quantitative lipid requirement and are most active at their physiological lipid conditions. In this respect, the lipid requirement of the E. coli SecYEG complex did not change significantly when pre-PhoB translocation was assayed3 instead of pro-OmpA.

Anionic phospholipids have been shown to fulfill at least a dual role, i.e. they promote SecA membrane binding and insertion and stimulate the interaction of the signal sequence of preproteins and the membrane (50). These lipids may indirectly stimulate targeting of SecA to the SecYEG complex, for instance by promoting the low affinity membrane binding of SecA. This may result in a membrane-bound pool of SecA protein that could have a kinetic advantage relative to the cytosolic pool to associate with SecYEG complexes that have completed a translocation reaction. Experimental evidence for such mechanism is, however, difficult to obtain. Another possible role for anionic phospholipids may be found in the putative assembly of the SecYEG complex into larger functional oligomers. The collective cold-sensitive secretion defect of the secG null and secAcsR11 strain (28) and many other Sec mutants may be found in a compromised channel assembly activity.

The reconstitution studies with the purified SecYEG complex provide compelling evidence that non-bilayer lipids stimulate translocation. The activating effect of DOPE can be mimicked with dioleoylglycerol, a lipid that like DOPE adopts a non-bilayer conformation, whereas bilayer-forming PE derivatives fail to stimulate translocation. These data provide strong evidence that the lipid shape is the major factor for activation rather than the amino group of PE. In contrast to the E. coli SecYEG, the activity of the B. subtilis SecYEG strictly required the presence of non-bilayer lipids. In contrast, the amino group of PE is needed for the functional reconstitution of the lactose permease of E. coli (55, 56) and leucine permease of Lactococcus lactis (57). PE stimulates the folding of the lactose permease into its active conformation (58, 59). Likewise, non-bilayer lipids may be needed for folding and/or assembly of the SecYEG complex.

Our data suggest that the absolute amounts of bilayer (or anionic) and non-bilayer lipids are essential for optimal activity. Since these lipids are needed at high concentration, it seems that the protein translocation activity is determined by the collective, physical properties of the membrane. The requirement for non-bilayer lipids could relate to their effect on the lateral membrane pressure and/or optimal matching of the protein-lipid interface and thus affect the conformation of the active translocase.

    ACKNOWLEDGEMENTS

We thank Jeanine de Keyzer, Erik Manting, Gert Moll, and Andreas Veenendaal for technical assistance and fruitful discussions.

    FOOTNOTES

* This work was supported by a PIONIER grant of the Netherlands Organization for Scientific Research (N.W.O.) and by CEC Biotech Grants BIO2 CT 930254 and BIO4 CT 960097.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 31-50-3632164; Fax: 31-50-3632154; E-mail: A.J.M.DRIESSEN@BIOL.RUG.NL.

2 A. Veenendaal, manuscript in preparation.

3 C. van der Does, J. Swaving, W. van Klompenburg, and A. J. M. Driessen, unpublished results.

    ABBREVIATIONS

The abbreviations used are: PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PS, phosphatidylserine; CL, cardiolipin; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; methyl-DOPE, N-methyl-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; dimethyl-DOPE, N,N-dimethyl-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; DMPE, 1,2-dimyristoyl-oleoyl-sn-glycero-3-phosphoethanolamine; DOPS, 1,2-dioleoyl-sn-glycero-3-[phospho-L-serine]; DOPG, 1,2-dioleoyl-sn-glycero-3-phosphoglycerol; DOG, dioleoylglycerol; OG, n-octyl beta -glucopyranoside; DDM, dodecyl maltoside; IMVs, inner membrane vesicles; PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Wickner, W., and Leonard, M. R. (1996) J. Biol. Chem. 271, 29514-29516[Free Full Text]
2. Danese, P. N., and Silhavy, T. J. (1998) Annu. Rev. Genet. 32, 59-94[CrossRef][Medline] [Order article via Infotrieve]
3. Driessen, A. J. M., Fekkes, P., and van der Wolk, J. P. W. (1998) Curr. Opin. Microbiol. 1, 216-222[CrossRef][Medline] [Order article via Infotrieve]
4. Akimaru, J., Matsuyama, S., Tokuda, H., and Mizushima, S. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6545-6549[Abstract/Free Full Text]
5. Brundage, L., Hendrick, J. P., Schiebel, E., Driessen, A. J. M., and Wickner, W. (1990) Cell 62, 649-657[CrossRef][Medline] [Order article via Infotrieve]
6. Duong, F., and Wickner, W. (1997) EMBO J. 16, 2756-2768[CrossRef][Medline] [Order article via Infotrieve]
7. van der Wolk, J. P., de Wit, J. G., and Driessen, A. J. M. (1997) EMBO J. 16, 7297-7304[CrossRef][Medline] [Order article via Infotrieve]
8. Driessen, A. J. M. (1992) EMBO J. 11, 847-853[Medline] [Order article via Infotrieve]
9. Dowhan, W. (1997) Annu. Rev. Biochem. 66, 199-232[CrossRef][Medline] [Order article via Infotrieve]
10. de Vrije, T., de Swart, R. L., Dowhan, W., Tommassen, J., and de Kruijff, B. (1988) Nature 334, 173-175[CrossRef][Medline] [Order article via Infotrieve]
11. Hendrick, J. P., and Wickner, W. (1991) J. Biol. Chem. 266, 24596-24600[Abstract/Free Full Text]
12. Tokuda, H., Shiozuka, K., and Mizushima, S. (1990) Eur. J. Biochem. 192, 583-589[Medline] [Order article via Infotrieve]
13. Kusters, R., Dowhan, W., and de Kruijff, B. (1991) J. Biol. Chem. 266, 8659-8662[Abstract/Free Full Text]
14. Lill, R., Dowhan, W., and Wickner, W. (1990) Cell 60, 271-280[CrossRef][Medline] [Order article via Infotrieve]
15. Ulbrandt, N. D., London, E., and Oliver, D. B. (1992) J. Biol. Chem. 267, 15184-15192[Abstract/Free Full Text]
16. Breukink, E., Demel, R. A., de Korte-Kool, G., and de Kruijff, B. (1992) Biochemistry 31, 1119-1124[CrossRef][Medline] [Order article via Infotrieve]
17. Kusters, R., Huijbregts, R., and de Kruijff, B. (1992) FEBS Lett. 308, 97-100[CrossRef][Medline] [Order article via Infotrieve]
18. Keller, R. C., Killian, J. A., and de Kruijff, B. (1992) Biochemistry 31, 1672-1677[CrossRef][Medline] [Order article via Infotrieve]
19. Keller, R. C., ten Berge, D., Nouwen, N., Snel, M. M., Tommassen, J., Marsh, D., and de Kruijff, B. (1996) Biochemistry 35, 3063-3071[CrossRef][Medline] [Order article via Infotrieve]
20. Leenhouts, J. M., van den Wijngaard, P. W., de Kroon, A. I., and de Kruijff, B. (1995) FEBS Lett. 370, 189-192[CrossRef][Medline] [Order article via Infotrieve]
21. van Raalte, A. L., Demel, R. A., Verberkmoes, G., Breukink, E., Keller, R. C., and de Kruijff, B. (1996) Eur. J. Biochem. 235, 207-214[Medline] [Order article via Infotrieve]
22. Phoenix, D. A., Kusters, R., Hikita, C., Mizushima, S., and de Kruijff, B. (1993) J. Biol. Chem. 268, 17069-17073[Abstract/Free Full Text]
23. Driessen, A. J. M., and Wickner, W. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 3107-3111[Abstract/Free Full Text]
24. van Klompenburg, W., Nilsson, I., von Heijne, G., and de Kruijff, B. (1997) EMBO J. 16, 4261-4266[CrossRef][Medline] [Order article via Infotrieve]
25. Kontinen, V. P., and Tokuda, H. (1995) FEBS Lett. 364, 157-160[CrossRef][Medline] [Order article via Infotrieve]
26. Shimizu, H., Nishiyama, K., and Tokuda, H. (1997) Mol. Microbiol. 26, 1013-1021[CrossRef][Medline] [Order article via Infotrieve]
27. Kontinen, V. P., Helander, I. M., and Tokuda, H. (1996) FEBS Lett. 389, 281-284[CrossRef][Medline] [Order article via Infotrieve]
28. Suzuki, H., Nishiyama, K., and Tokuda, H. (1999) J. Biol. Chem. 274, 31020-31024[Abstract/Free Full Text]
29. van Voorst, F., van der Does, C., Brunner, J., Driessen, A. J. M., and de Kruijff, B. (1998) Biochemistry 37, 12261-12268[CrossRef][Medline] [Order article via Infotrieve]
30. Eichler, J., Brunner, J., and Wickner, W. (1997) EMBO J. 16, 2188-2196[CrossRef][Medline] [Order article via Infotrieve]
31. Ellens, H., Bentz, J., and Szoka, F. C. (1986) Biochemistry 25, 4141-4147[CrossRef][Medline] [Order article via Infotrieve]
32. DeChavigny, A., Heacock, P. N., and Dowhan, W. (1991) J. Biol. Chem. 266, 5323-5332[Abstract/Free Full Text]
33. Rietveld, A. G., Killian, J. A., Dowhan, W., and de Kruijff, B. (1993) J. Biol. Chem. 268, 12427-12433[Abstract/Free Full Text]
34. Rietveld, A. G., Chupin, V. V., Koorengevel, M. C., Wienk, H. L., Dowhan, W., and de Kruijff, B. (1994) J. Biol. Chem. 269, 28670-28675[Abstract/Free Full Text]
35. Rietveld, A. G., Koorengevel, M. C., and de Kruijff, B. (1995) EMBO J. 14, 5506-5513[Medline] [Order article via Infotrieve]
36. Rand, R. P., and Sengupta, S. (1972) Biochim. Biophys. Acta 255, 484-492[Medline] [Order article via Infotrieve]
37. Ahn, T., and Kim, H. (1998) J. Biol. Chem. 273, 21692-21698[Abstract/Free Full Text]
38. Kaufmann, A., Manting, E. H., Veenendaal, A. K., Driessen, A. J. M., and van der Does, C. (1999) Biochemistry 38, 9115-9125[CrossRef][Medline] [Order article via Infotrieve]
39. van der Does, C., Manting, E. H., Kaufmann, A., Lutz, M., and Driessen, A. J. M. (1998) Biochemistry 37, 201-210[CrossRef][Medline] [Order article via Infotrieve]
40. Cabelli, R. J., Chen, L., Tai, P. C., and Oliver, D. B. (1988) Cell 55, 683-692[CrossRef][Medline] [Order article via Infotrieve]
41. Klose, M., Schimz, K. L., van der Wolk, J., Driessen, A. J. M., and Freudl, R. (1993) J. Biol. Chem. 268, 4504-4510[Abstract/Free Full Text]
42. Weiss, J. B., Ray, P. H., and Bassford, P. J., Jr. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 8978-8982[Abstract/Free Full Text]
43. Crooke, E., Guthrie, B., Lecker, S., Lill, R., and Wickner, W. (1988) Cell 54, 1003-1011[CrossRef][Medline] [Order article via Infotrieve]
44. van Wely, K. H. M., Swaving, J., and Driessen, A. J. M. (1998) Eur. J. Biochem. 255, 690-697[Medline] [Order article via Infotrieve]
45. Swaving, J., van Wely, K. H. M., and Driessen, A. J. M. (1999) J. Bacteriol 181, 7021-7027[Abstract/Free Full Text]
46. Lill, R., Cunningham, K., Brundage, L. A., Ito, K., Oliver, D., and Wickner, W. (1989) EMBO J. 8, 961-966[Medline] [Order article via Infotrieve]
47. Rouser, G., Fleischer, S., and Yamamoto, A. (1970) Lipids 5, 494-496[Medline] [Order article via Infotrieve]
48. Mulukutla, S., and Shipley, G. G. (1984) Biochemistry 23, 2514-2519[CrossRef][Medline] [Order article via Infotrieve]
49. Krulwich, T. A., Clejan, S., Falk, L. H., and Guffanti, A. A. (1987) J. Bacteriol. 169, 4479-4485[Abstract/Free Full Text]
50. van Klompenburg, W., and de Kruijff, B. (1998) J. Membr. Biol. 162, 1-7[CrossRef][Medline] [Order article via Infotrieve]
51. Brundage, L., Fimmel, C. J., Mizushima, S., and Wickner, W. (1992) J. Biol. Chem. 267, 4166-4170[Abstract/Free Full Text]
52. Duong, F., and Wickner, W. (1999) EMBO J. 18, 3263-3270[CrossRef][Medline] [Order article via Infotrieve]
53. Meyer, T. H., Ménétret, J. F., Breitling, R., Miller, K. R., Akey, C. W., and Rapoport, T. A. (1999) J. Mol. Biol. 285, 1789-1800[CrossRef][Medline] [Order article via Infotrieve]
54. Matlack, K. E., Plath, K., Misselwitz, B., and Rapoport, T. A. (1997) Science 277, 938-941[Abstract/Free Full Text]
55. Chen, C. C., and Wilson, T. H. (1984) J. Biol. Chem. 259, 10150-10158[Abstract/Free Full Text]
56. Seto-Young, D., Chen, C. C., and Wilson, T. H. (1985) J. Membr. Biol. 84, 259-267[CrossRef][Medline] [Order article via Infotrieve]
57. Driessen, A. J. M., Zheng, T., In't Veld, G., Op den Kamp, J. A. F., and Konings, W. N. (1988) Biochemistry 27, 865-872[CrossRef][Medline] [Order article via Infotrieve]
58. Bogdanov, M., Umeda, M., and Dowhan, W. (1999) J. Biol. Chem. 274, 12339-12345[Abstract/Free Full Text]
59. Bogdanov, M., Sun, J., Kaback, H. R., and Dowhan, W. (1996) J. Biol. Chem. 271, 11615-11618[Abstract/Free Full Text]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Wikstrom, A. A. Kelly, A. Georgiev, H. M. Eriksson, M. R. Klement, M. Bogdanov, W. Dowhan, and A. Wieslander
Lipid-engineered Escherichia coli Membranes Reveal Critical Lipid Headgroup Size for Protein Function
J. Biol. Chem., January 9, 2009; 284(2): 954 - 965.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
C. Sun, S. L. Rusch, J. Kim, and D. A. Kendall
Chloroplast SecA and Escherichia coli SecA Have Distinct Lipid and Signal Peptide Preferences
J. Bacteriol., February 1, 2007; 189(3): 1171 - 1175.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Or, D. Boyd, S. Gon, J. Beckwith, and T. Rapoport
The Bacterial ATPase SecA Functions as a Monomer in Protein Translocation
J. Biol. Chem., March 11, 2005; 280(10): 9097 - 9105.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Natale, J. Swaving, C. van der Does, J. de Keyzer, and A. J. M. Driessen
Binding of SecA to the SecYEG Complex Accelerates the Rate of Nucleotide Exchange on SecA
J. Biol. Chem., April 2, 2004; 279(14): 13769 - 13777.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Wikstrom, J. Xie, M. Bogdanov, E. Mileykovskaya, P. Heacock, A. Wieslander, and W. Dowhan
Monoglucosyldiacylglycerol, a Foreign Lipid, Can Substitute for Phosphatidylethanolamine in Essential Membrane-associated Functions in Escherichia coli
J. Biol. Chem., March 12, 2004; 279(11): 10484 - 10493.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. van der Laan, N. Nouwen, and A. J. M. Driessen
SecYEG Proteoliposomes Catalyze the {Delta}{phi}-Dependent Membrane Insertion of FtsQ
J. Biol. Chem., January 16, 2004; 279(3): 1659 - 1664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Zhang, M. Bogdanov, J. Pi, A. J. Pittard, and W. Dowhan
Reversible Topological Organization within a Polytopic Membrane Protein Is Governed by a Change in Membrane Phospholipid Composition
J. Biol. Chem., December 12, 2003; 278(50): 50128 - 50135.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. de Keyzer, C. van der Does, T. G. Kloosterman, and A. J. M. Driessen
Direct Demonstration of ATP-dependent Release of SecA from a Translocating Preprotein by Surface Plasmon Resonance
J. Biol. Chem., August 8, 2003; 278(32): 29581 - 29586.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Benach, Y.-T. Chou, J. J. Fak, A. Itkin, D. D. Nicolae, P. C. Smith, G. Wittrock, D. L. Floyd, C. M. Golsaz, L. M. Gierasch, et al.
Phospholipid-induced Monomerization and Signal-peptide-induced Oligomerization of SecA
J. Biol. Chem., January 31, 2003; 278(6): 3628 - 3638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Basanez, J. C. Sharpe, J. Galanis, T. B. Brandt, J. M. Hardwick, and J. Zimmerberg
Bax-type Apoptotic Proteins Porate Pure Lipid Bilayers through a Mechanism Sensitive to Intrinsic Monolayer Curvature
J. Biol. Chem., December 13, 2002; 277(51): 49360 - 49365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ahn, D.-B. Oh, H. Kim, and C. Park
The Phase Property of Membrane Phospholipids Is Affected by the Functionality of Signal Peptides from the Escherichia coli Ribose-binding Protein
J. Biol. Chem., July 12, 2002; 277(29): 26157 - 26162.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. Birner, M. Bürgermeister, R. Schneiter, and G. Daum
Roles of Phosphatidylethanolamine and of Its Several Biosynthetic Pathways in Saccharomyces cerevisiae
Mol. Biol. Cell, April 1, 2001; 12(4): 997 - 1007.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. S. Millman, H.-Y. Qi, F. Vulcu, H. D. Bernstein, and D. W. Andrews
FtsY Binds to the Escherichia coli Inner Membrane via Interactions with Phosphatidylethanolamine and Membrane Proteins
J. Biol. Chem., July 6, 2001; 276(28): 25982 - 25989.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. L. Triplett, A. R. Sgrignoli, F.-B. Gao, Y.-B. Yang, P. C. Tai, and L. M. Gierasch
Functional Signal Peptides Bind a Soluble N-terminal Fragment of SecA and Inhibit Its ATPase Activity
J. Biol. Chem., May 25, 2001; 276(22): 19648 - 19655.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Does, C.
Right arrow Articles by Driessen, A. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Does, C.
Right arrow Articles by Driessen, A. J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement